Stratifying vascular disease patients into homogeneous subgroups using machine learning and FLAIR MRI biomarkers.
Source check: Source checked. Not independent scientific confirmation.
Finding: Five imaging-defined groups showed distinct vascular and cerebral characteristics in the observed atherosclerosis cohort. The bibliographic records retrieved do not state an author affiliation.
Technology: K-means grouped regional FLAIR features, with a random forest identifying markers differentiating the groups.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- K-means grouped regional FLAIR features, with a random forest identifying markers differentiating the groups.
- Test and result
- In 379 patients the groups differed in clinical and imaging measures, including vascular risks and white matter lesion burden.
- Limitation / still unknown
- Five imaging-defined groups showed distinct vascular and cerebral characteristics in the observed atherosclerosis cohort. Internal statistical comparison of reported clinical and lesion covariates supports exploratory cohort stratification. No independent replication or treatment effect was established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s44303-024-00063-x
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.